Stock Information
Gyre Therapeutics Inc (GYRE)
Ticker Symbol: GYRE
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $793.62 mil
Piotroski score: 5
PE Ratio: 127.2863
EPS (TTM): 0.0466
Revenue (TTM): $1.28 M
Dividend Yield: N/A%
ROE: 5.46%
Latest News
-
Gyre Therapeutics Gets Priority Review In China For Hepatitis B Liver Damage Drug
Tue, Mar 17, 2026 7:04 AM
Key Financials
Financial data not available